Announcements Trials
Browse Landscape

Status

Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Recurrence 3Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 2Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1HER2-positive Breast Cancer 1Glioma 1EGFRm Advanced Non-Small Cell Lung Cancer 1Cholangiocarcinoma 1Carcinoma, Basal Cell 1Advanced Cancers and FGFR Genetic Alterations 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Approved for marketing × EGFRm Advanced Non-Small Cell Lung Cancer × 1 year × Clear all
NCT06279728 2025-07-03

Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients

Daiichi Sankyo

Approved for marketing
Thoracic

EGFRm Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡